fluconazole has been researched along with vorinostat in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 4 (40.00) | 2.80 |
Authors | Studies |
---|---|
Brosch, G; Mai, A; Massa, S; Palamara, AT; Passariello, C; Rotili, D; Simonetti, G | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dong, G; Huang, Y; Li, H; Liu, N; Sheng, C; Zhang, W | 1 |
Han, G; Li, C; Li, Z; Liu, N; Sheng, C; Tu, J | 1 |
Han, G; Li, Z; Liu, N; Sheng, C; Tu, J | 1 |
Chen, X; Li, C; Liu, N; Sheng, C; Tu, J; Xu, D; Zhu, T | 1 |
Han, G; Li, C; Liu, N; Sheng, C; Tu, J | 1 |
1 review(s) available for fluconazole and vorinostat
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for fluconazole and vorinostat
Article | Year |
---|---|
Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.
Topics: Antifungal Agents; Candida albicans; Drug Resistance, Fungal; Enzyme Inhibitors; Fluconazole; Histone Deacetylase Inhibitors; Hydroxamic Acids; Microbial Sensitivity Tests; Structure-Activity Relationship; Uracil | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections.
Topics: Animals; Apoptosis; Candida albicans; Cell Cycle; Cell Line, Tumor; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Invasive Fungal Infections; Janus Kinase 2; Leukemia, Myeloid, Acute; Mice | 2018 |
Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis.
Topics: 14-alpha Demethylase Inhibitors; Animals; Azoles; Candida albicans; Candidiasis; Cytochrome P450 Family 51; Drug Discovery; Drug Resistance, Fungal; Female; Histone Deacetylase Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred ICR; Sterol 14-Demethylase; Treatment Outcome | 2020 |
Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis.
Topics: Animals; Azoles; Biofilms; Candida albicans; Candidiasis; Carbolines; Drug Resistance, Fungal; Drug Therapy, Combination; Female; Fluconazole; Fungal Proteins; Fungi; Histone Deacetylase Inhibitors; Humans; Liver; Membrane Transport Proteins; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 2021 |
Lanosterol 14α-demethylase (CYP51)/histone deacetylase (HDAC) dual inhibitors for treatment of Candida tropicalis and Cryptococcus neoformans infections.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Candida tropicalis; Candidiasis, Cutaneous; Cryptococcosis; Cryptococcus neoformans; Cytochrome P450 Family 51; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Histone Deacetylase Inhibitors; Histone Deacetylases; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
Heat shock protein 90 (Hsp90)/Histone deacetylase (HDAC) dual inhibitors for the treatment of azoles-resistant Candida albicans.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; HSP90 Heat-Shock Proteins; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2022 |